In conclusion, this study demonstrated that the overexpression of CD47 and SIRPα, particularly in tandem, is significantly associated with poor prognoses among patients with resectable ESCC, with CD47 CPS identified as an independent prognostic factor. This evidence concerns the gene SIRPA and esophageal squamous cell carcinoma.